10X Genomics
TXG
$24.80
+5.17%
TXG price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on 10X Genomics's 12-month outlook, with a consensus price target around $32.24 and implied upside of +30.0% versus the current price.
Average Target
$32.24
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$20 - $32
Analyst target range
TXG Technical Analysis
Beta
2.17
2.17x market volatility
Max Drawdown
-34.2%
Largest decline past year
52-Week Range
$7-$25
Price range past year
Annual Return
+199.7%
Cumulative gain past year
| Period | TXG Return | S&P 500 |
|---|---|---|
| 1m | +32.0% | +4.9% |
| 3m | +18.5% | +0.6% |
| 6m | +100.3% | +5.1% |
| 1y | +199.7% | +28.8% |
| ytd | +49.2% | +1.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is TXG Overvalued?
PE
-46.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-15.5x
Enterprise Value Multiple